Results of a Phase 1 Clinical Trial to Determine the Safety and Tolerability of GH002

Mebufotenin, also known as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), is a potent psychedelic drug belonging to a group of psychoactive indole-alkylamine drugs.